261 related articles for article (PubMed ID: 22138288)
21. Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration.
Hsu CJ; Lin TY; Kuo CC; Tsai CH; Lin MZ; Hsu HC; Fong YC; Tang CH
J Cell Biochem; 2010 Sep; 111(1):138-47. PubMed ID: 20506523
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Yeh YY; Chiao CC; Kuo WY; Hsiao YC; Chen YJ; Wei YY; Lai TH; Fong YC; Tang CH
Biochem Pharmacol; 2008 Mar; 75(6):1292-301. PubMed ID: 18191107
[TBL] [Abstract][Full Text] [Related]
23. IL-8 increases integrin expression and cell motility in human chondrosarcoma cells.
Lee CY; Huang CY; Chen MY; Lin CY; Hsu HC; Tang CH
J Cell Biochem; 2011 Sep; 112(9):2549-57. PubMed ID: 21590707
[TBL] [Abstract][Full Text] [Related]
24. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
25. Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-kappaB pathways.
Su CM; Lu DY; Hsu CJ; Chen HT; Huang CY; Yang WH; Su YC; Yang SN; Fong YC; Tseng WP; Tang CH
J Cell Physiol; 2009 Aug; 220(2):499-507. PubMed ID: 19399830
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
29. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
Moon SK; Cha BY; Kim CH
J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
31. HMGB-1 induces cell motility and α5β1 integrin expression in human chondrosarcoma cells.
Tang CH; Keng YT; Liu JF
Cancer Lett; 2012 Sep; 322(1):98-106. PubMed ID: 22361176
[TBL] [Abstract][Full Text] [Related]
32. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
Lin CW; Shen SC; Chien CC; Yang LY; Shia LT; Chen YC
J Cell Physiol; 2010 Nov; 225(2):472-81. PubMed ID: 20458747
[TBL] [Abstract][Full Text] [Related]
33. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
34. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
35. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.
Mengshol JA; Vincenti MP; Coon CI; Barchowsky A; Brinckerhoff CE
Arthritis Rheum; 2000 Apr; 43(4):801-11. PubMed ID: 10765924
[TBL] [Abstract][Full Text] [Related]
37. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
38. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
Yang MD; Lai KC; Lai TY; Hsu SC; Kuo CL; Yu CS; Lin ML; Yang JS; Kuo HM; Wu SH; Chung JG
Anticancer Res; 2010 Jun; 30(6):2135-43. PubMed ID: 20651362
[TBL] [Abstract][Full Text] [Related]
39. Plasmin induces in vivo monocyte recruitment through protease-activated receptor-1-, MEK/ERK-, and CCR2-mediated signaling.
Carmo AA; Costa BR; Vago JP; de Oliveira LC; Tavares LP; Nogueira CR; Ribeiro AL; Garcia CC; Barbosa AS; Brasil BS; Dusse LM; Barcelos LS; Bonjardim CA; Teixeira MM; Sousa LP
J Immunol; 2014 Oct; 193(7):3654-63. PubMed ID: 25165151
[TBL] [Abstract][Full Text] [Related]
40. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
